Total trials
93
Active
15
Phase 3
0
Total enrollment
18,929
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Semaglutide 0.25 mg | — | — | — | — | — | 1 |
Next readouts
- 2026-12
Top conditions
- Blood Pressure5
- Ileostomy - Stoma4
- Vitamin D Deficiency4
- Stroke4
- Cardiovascular Disease3
- Healthy Nutrition3
- Healthy3
- Bronchiectasis3
Frequently asked questions about University of Ulster
- How many clinical trials does University of Ulster have on ClinicalTrials.gov?
- University of Ulster is listed as the lead sponsor on 93 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Ulster's trials are in Phase 3?
- 0 of University of Ulster's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Ulster focus on?
- University of Ulster's most-studied conditions on ClinicalTrials.gov are Blood Pressure, Ileostomy - Stoma, Vitamin D Deficiency, Stroke, Cardiovascular Disease.
- When are University of Ulster's next clinical trial readouts?
- University of Ulster has 1 upcoming primary-completion readout tracked here; the soonest is “Free Fatty Acid Effects In Type 2 Diabetes”, expected around 2026-12.